0

Coronary Risk Factors Collection
 61-80 of 222 Articles
ACP Journal Club |  19 March 2013
Review: Continuous glucose monitoring reduces HbA1c more than self-monitoring in type 1 diabetes
A.C. Felix Burden, MD
Ann Intern Med. 2013;158(6):JC9. doi:10.7326/0003-4819-158-6-201303190-02009
ACP Journal Club |  15 January 2013
A single screening for type 2 diabetes in high-risk adults did not reduce mortality over 10 years
Jeffrey Mahon, MD, MSc
Ann Intern Med. 2013;158(2):JC4. doi:10.7326/0003-4819-158-2-201301150-02004
ACP Journal Club |  15 January 2013
Review: Intensive blood pressure control reduces stroke, but not mortality or MI, in type 2 diabetes
Louise Moist, MD
Ann Intern Med. 2013;158(2):JC5. doi:10.7326/0003-4819-158-2-201301150-02005
ACP Journal Club |  18 December 2012
Review: Omega-3 polyunsaturated fatty acid supplements do not reduce major cardiovascular events in adults
Donald A. Smith, MD, MPH, FACP, FNLA
Ann Intern Med. 2012;157(12):JC6-5. doi:10.7326/0003-4819-157-12-201212180-02005
ACP Journal Club |  18 December 2012
Review: Low-quality evidence fails to show that antihypertensive drugs affect outcomes in mild hypertension
James Brophy, MD, FRCP, PhD
Ann Intern Med. 2012;157(12):JC6-6. doi:10.7326/0003-4819-157-12-201212180-02006
ACP Journal Club |  18 December 2012
Review: Statins reduce pancreatitis in adults with normal or mildly elevated triglyceride levels
Hanna E. Bloomfield, MD, MPH
Ann Intern Med. 2012;157(12):JC6-8. doi:10.7326/0003-4819-157-12-201212180-02008
ACP Journal Club |  18 December 2012
Review: Eplerenone is not more effective for reducing mortality than other aldosterone antagonists
Ellis Lader, MD, FACC
Ann Intern Med. 2012;157(12):JC6-10. doi:10.7326/0003-4819-157-12-201212180-02010
ACP Journal Club |  18 December 2012
Novel risk markers improved Framingham Risk Score cardiovascular event prediction in intermediate-risk adults
Daniel I. Steinberg, MD
Ann Intern Med. 2012;157(12):JC6-13. doi:10.7326/0003-4819-157-12-201212180-02013
ACP Journal Club |  20 November 2012
Review: Statins decrease mortality and major CV events in adults with CKD not receiving dialysis
G. V. Ramesh Prasad, MBBS, FRCPC
Ann Intern Med. 2012;157(10):JC5-4. doi:10.7326/0003-4819-157-10-201211200-02004
ACP Journal Club |  20 November 2012
Review: Lipid-lowering drugs decrease all-cause and cardiac mortality and CV events in CKD
G. V. Ramesh Prasad, MBBS, FRCPC
Ann Intern Med. 2012;157(10):JC5-5. doi:10.7326/0003-4819-157-10-201211200-02005
ACP Journal Club |  20 November 2012
Review: Intensive glucose control reduces surrogate, but not clinical, renal outcomes in type 2 diabetes
Eugene C. Corbett Jr., MD, MACP
Ann Intern Med. 2012;157(10):JC5-6. doi:10.7326/0003-4819-157-10-201211200-02006
ACP Journal Club |  16 October 2012
Meta-analysis: Lowering LDL-C levels using statins reduces major vascular events regardless of baseline risk
Meera Jain, MD; Mark Rosenberg, MD
Ann Intern Med. 2012;157(8):JC4-2. doi:10.7326/0003-4819-157-8-201210160-02002
ACP Journal Club |  16 October 2012
Intensive BP control and/or glucose control did not reduce microvascular events in hypertensive type 2 diabetes
Juan P. Brito, MD; Victor M. Montori, MD, MSc
Ann Intern Med. 2012;157(8):JC4-7. doi:10.7326/0003-4819-157-8-201210160-02007
ACP Journal Club |  16 October 2012
Review: Quality improvement strategies reduce HbA1c, LDL cholesterol, and BP in diabetes
Sean F. Dinneen, MD; Máire O’Donnell, PhD
Ann Intern Med. 2012;157(8):JC4-11. doi:10.7326/0003-4819-157-8-201210160-02011
ACP Journal Club |  18 September 2012
Review: Varenicline is better than bupropion but not nicotine patch for smoking abstinence in adults
Allan V. Prochazka, MD; Tanner J. Caverly, MD
Ann Intern Med. 2012;157(6):JC3-7. doi:10.7326/0003-4819-157-6-201209180-02007
ACP Journal Club |  18 September 2012
Glargine did not reduce CV events more than standard care in patients with dysglycemia
Ellis Lader, MD
Ann Intern Med. 2012;157(6):JC3-10. doi:10.7326/0003-4819-157-6-201209180-02010
ACP Journal Club |  18 September 2012
Daily n-3 fatty acid supplements did not reduce CV events in high-risk patients with dysglycemia
Ellis Lader, MD
Ann Intern Med. 2012;157(6):JC3-11. doi:10.7326/0003-4819-157-6-201209180-02011
ACP Journal Club |  21 August 2012
Review: Varenicline for tobacco cessation does not increase CV serious adverse events
Paul Krebs, PhD; Scott E. Sherman, MD, MPH
Ann Intern Med. 2012;157(4):JC2-2. doi:10.7326/0003-4819-157-4-201208210-02002
ACP Journal Club |  20 March 2012
Simvastatin reduced major vascular events at 5 years in at-risk patients; benefits were maintained at 11 years
Edward P. Havranek, MD
Ann Intern Med. 2012;156(6):JC3-5. doi:10.7326/0003-4819-156-6-201202210-02005
ACP Journal Club |  20 March 2012
Review: Statins do not increase risk for intracerebral hemorrhage
David C. Anderson, MD
Ann Intern Med. 2012;156(6):JC3-6. doi:10.7326/0003-4819-156-6-201202210-02006
Advertisement
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)